HaddAGSilvestroAMcKelveyBA, et al.Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium. Clin Transl Sci. 2025 Mar;18(3):e70185. doi: 10.1111/cts.70185
2.
SurayaRNaganoTTachiharaM. Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities. Cancers (Basel). 2025;17(4):694. Published 2025 Feb 18. doi:10.3390/cancers17040694
3.
ReussJELeePKMehranRJ, et al.Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses. Nat Med. 2025. doi:10.1038/s41591-025-03958-3
